Sergio Zuniga1, Alvaro Sanabria. 1. Head and Neck Surgery Unit, Department of Surgery, Clinica Las Americas, Medellin, Colombia.
Abstract
OBJECTIVE: To assess the disease-free survival results of prophylactic central neck dissection for papillary thyroid carcinoma preoperatively staged as N0. DESIGN: Inception cohort. SETTING: Head and neck surgery unit at a national oncologic center. PATIENTS: Patients with a histologically confirmed diagnosis of stage N0 papillary thyroid cancer but no previous oncologic treatment, no recurrent tumor, and no distant metastasis. INTERVENTION: Central neck dissection intended as curative treatment. MAIN OUTCOME MEASURE: Disease-free survival. Demographic, clinical, therapeutic, pathologic, and neck recurrence information was also collected. RESULTS: A total of 266 patients were included. Mean (SD) follow-up time was 6.9 (4.3) years. Ninety percent of patients had a follow-up longer than 2 years. Prophylactic central neck dissection was performed in 136 patients (51.3%). Of those patients who underwent central neck dissection, 112 had metastatic lymph nodes (82.3%). Neck recurrence occurred in 45 patients (16.9%). Overall, 5-year neck disease-free survival was 86.8%; it was 88.2% in the central neck dissection group vs 85.6% in the group that did not undergo central neck dissection (P = .72). In the multivariate analysis, factors related to central neck dissection were macroscopic extrathyroidal extension (odds ratio [OR], 2.12; 95% confidence interval [CI], 1.19-3.79) and multifocality (OR, 3.96; 95% CI, 2.08-7.53). In Cox multivariate analysis for disease-free survival, central neck dissection did not show any significant effect. CONCLUSION: Prophylactic central neck dissection did not show any advantage in the rate of neck recurrence in patients with N0 clinical stage disease.
OBJECTIVE: To assess the disease-free survival results of prophylactic central neck dissection for papillary thyroid carcinoma preoperatively staged as N0. DESIGN: Inception cohort. SETTING: Head and neck surgery unit at a national oncologic center. PATIENTS: Patients with a histologically confirmed diagnosis of stage N0 papillary thyroid cancer but no previous oncologic treatment, no recurrent tumor, and no distant metastasis. INTERVENTION: Central neck dissection intended as curative treatment. MAIN OUTCOME MEASURE: Disease-free survival. Demographic, clinical, therapeutic, pathologic, and neck recurrence information was also collected. RESULTS: A total of 266 patients were included. Mean (SD) follow-up time was 6.9 (4.3) years. Ninety percent of patients had a follow-up longer than 2 years. Prophylactic central neck dissection was performed in 136 patients (51.3%). Of those patients who underwent central neck dissection, 112 had metastatic lymph nodes (82.3%). Neck recurrence occurred in 45 patients (16.9%). Overall, 5-year neck disease-free survival was 86.8%; it was 88.2% in the central neck dissection group vs 85.6% in the group that did not undergo central neck dissection (P = .72). In the multivariate analysis, factors related to central neck dissection were macroscopic extrathyroidal extension (odds ratio [OR], 2.12; 95% confidence interval [CI], 1.19-3.79) and multifocality (OR, 3.96; 95% CI, 2.08-7.53). In Cox multivariate analysis for disease-free survival, central neck dissection did not show any significant effect. CONCLUSION: Prophylactic central neck dissection did not show any advantage in the rate of neck recurrence in patients with N0 clinical stage disease.
Authors: Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra Journal: Langenbecks Arch Surg Date: 2013-12-19 Impact factor: 3.445
Authors: Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl Journal: Eur Arch Otorhinolaryngol Date: 2014-06-11 Impact factor: 2.503
Authors: Seo Ki Kim; Jung-Woo Woo; Inhye Park; Jun Ho Lee; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim Journal: Langenbecks Arch Surg Date: 2016-10-24 Impact factor: 3.445
Authors: Jason D Prescott; Peter M Sadow; Richard A Hodin; Long Phi Le; Randall D Gaz; Gregory W Randolph; Antonia E Stephen; Sareh Parangi; Gilbert H Daniels; Carrie C Lubitz Journal: Surgery Date: 2012-12 Impact factor: 3.982